Drug Targeting Organ-Specific Strategies

References 119
[133] Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G, Proc. Natl Acad. Sci. USA 1992,
89, 9991–9995.
[134] Zimmerman GA, Prescott SM, McIntyre TM, Immunol. Today 1992, 13, 93–100.
[135] Coulpier M, Andreev S, Lemercier C, Dauchel H, Lees O, Fontaine M, Ripoche J, Clin. Exp. Immunol.
1995, 101, 142–149.
[136] Didonato JA, Saatcioglu F, Karin M, Am. J. Respir. Crit. Care Med. 1996, 154, S11–5.
[137] Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M, Science 1995, 270, 286–290.
[138] Sheppard KA, Phelps KM, Williams AJ, Thanos D, Glass CK, Rosenfeld MG, Gerritsen ME,
Collins T, J. Biol. Chem. 1998, 273, 29291–29294.
[139] Chanarin N, Johnston SL, Drugs 1994, 47, 12–24.
[140] Brooks PM, Agents Actions (Suppl.), 1993, 44, 161–163.
[141] Muller R, J. Med. 1981, 12, 209–235.
[142] Sullivan GW, Carper HT, Novick Jr WJ, Mandell GL, Infect. Immun. 1988, 56, 1722–1729.
[143] Ward A, Clissold SP, Drugs 1987, 34, 50–97.
[144] Windmeier C, Gressner AM, Gen. Pharmacol. 1997, 29, 181–196.
[145] Schuppan D, Strobel D, Hahn EG, Digestion 1998, 59, 385–39
[146] Niki T, Rombouts K, De Bleser PJ, de Smet K, Rogiers V, Schuppan D, Yoshida M, Gabbiani G,
Geerts A, Hepatology 1999, 29, 858–867.
[147] Albrecht C, Meijer DKF, Lebbe C, Sägesser H, Melgert BN, Poelstra K, Reichen J, Hepatology.
1997, 26, 1553–1559.
[148] Melgert BN, Wartna E, Lebbe C, Albrecht C, Molema G, Poelstra K, Reichen J, Meijer DKF, J.
Drug Target. 1998, 5, 329–342.
[149] Albrecht C, Melgert BN, Reichen J, Poelstra K, Meijer DKF, J. Drug Target. 1998, 6, 105–117.
[150] Melgert BN, Poelstra K, Jack VK, Molema G, Meijer DKF, Hepatology 1998, 28, 440A.
[151] Rosenmund A, Kuyas C, Heberli A, Biochem. J. 1986, 240, 239–245.
[152] Melgert BN, Olinga P, Jack VK, Molema G, Meijer DKF, Poelstra K, J. Hepatol. 2000, 32,
603–611.
[153] Noda T, Mimura H, Orita K, Hepatogastroenterology 1990, 37, 319–323.
[154] Petermann H, Heymann S, Vogl S, Dargel R, J. Hepatol. 1996, 24, 468–477.
[155] Laurent TC, Laurent UB, Fraser JR, Ann. Med. 1996, 28, 241–253.
[156] Weiner JA, Chen A, Davis BH, J. Biol. Chem. 1998, 273, 15913–15919.
[157] Wong L, Yamasaki G, Johnson RJ, Friedman SL, J. Clin. Invest. 1994, 94, 1563–1569.
[158] Kountouras J, Billing BH, Scheuer PJ, Br. J. Exp. Pathol. 1984, 65, 305–311.
[159] Fischer-Nielsen A, Poulsen HE, Hansen BA, Hage E, Keiding S, J. Hepatol. 1991, 12, 110–117.
[160] Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D, Hepatology 1997, 26,
643–649.
[161] Braet F, De Zanger R, Sasaoki T, Baekeland M, Janssens P, Smedsrod B, Wisse E, Lab. Invest.
1994, 70, 944–952.
[162] Geerts A, Niki T, Hellemans K, De Craemer D, Van den Berg K, Lazou J-M, Stange G, Van de
Winkel M, De Bleser PJ, Hepatology 1998, 27, 590–598.
[163] Dong QG, Bernasconi S, Lostaglio S, De Calmanovici RW, Martin Padura I, Breviario F, Garlanda
C, Ramponi S, Mantovani A, and Vecchi A, Arterioscler. Thromb. Vasc. Biol. 1997, 17,
1599–1604.
[164] Kuiper J, Brouwer A, Knook DL, Van Berkel TJC, In: The Liver: Biology and Pathobiology (Eds
Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA), pp. 791–818. Raven
Press Ltd., New York, 1994.
[165] Melgert BN, Olinga P, Weert B, Slooff MJH, Meijer DKF, Poelstra K, Groothuis GMM, Drug
Metab. Dispos. 2001, 29, 361–367.
[166] Olinga P, Meijer DKF, Slooff MJH, Groothuis GMM, Toxicol. In Vitro 1997, 12, 77–100.
[167] Yamashiro DJ, Maxfield FR, J. Cell Biochem. 1984, 26, 231–246.
[168] Geuze HJ, Slot JW, Strous GJAM, Lodish HF, Schwartz AL, Cell 1983, 32, 1277–1287.
[169] De Duve C, Wattiaux R, Annu. Rev. Physiol. 1966, 28, 435–492.
[170] Thorens B, Vassalli P, Nature 1986, 321, 618–620.
[171] Clarke BL, Weigel PH, Biochem. J. 1989, 262, 277–284.
[172] Goltz JS, Wolkoff AW, Novikoff PM, Stockert RJ, Satir P, Proc. Natl Acad. Sci. USA 1992, 89,
7026–7030.
[173] Lebbe C, Reichen J, Wartna E, Sägesser H, Poelstra K, and Meijer DKF, J. Drug Target. 1997, 4,
303–310.
[174] Beljaars L, Poelstra K, Molema G, Meijer DKF, J. Hepatol. 1998, 29, 579–588.